Log on / register
Feedback | Support | My details
The use of microarray technologies in clinical oncology.
Gabriele L, Moretti F, Pierotti MA, Marincola FM, Foà R, Belardelli FM
J Transl Med 2006, 4:8
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Commentary    
A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"
Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D, Coukos G, Dhodapkar M, Håkansson L, Janetzki S, Kleen TO, Kirkwood JM, Maccalli C, Maecker H, Maio M, Malyguine A, Masucci G, Palucka AK, Potter DM, Ribas A, Rivoltini L, Schendel D, Seliger B, Selvan S, Slingluff CL, Stroncek DF, et al.
Journal of Translational Medicine 2008, 6:81 (23 December 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central] [1 comment]
2.


Hypothesis    
Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy?
Perez-Plasencia C, Duenas-Gonzalez A
Molecular Cancer 2006, 5:27 (10 July 2006)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
3.


Research    
Microarray evidence of glutaminyl cyclase gene expression in melanoma: implications for tumor antigen specific immunotherapy
Gillis JS
Journal of Translational Medicine 2006, 4:27 (4 July 2006)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.